Exsilio Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Exsilio Therapeutics's estimated annual revenue is currently $5.3M per year.
- Exsilio Therapeutics's estimated revenue per employee is $140,000
Employee Data
- Exsilio Therapeutics has 38 Employees.
- Exsilio Therapeutics grew their employee count by 52% last year.
Exsilio Therapeutics's People
| Name | Title | Email/Phone |
|---|
What Is Exsilio Therapeutics?
Exsilio Therapeutics is developing genomic medicines that can be delivered in lipid nanoparticles to durably and safely treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions. Exsilio’s technology is based on naturally occurring genetic elements that can precisely insert new genes into a cell through RNA intermediate templates. Exsilio uses predictive in silico modeling and wet lab-based experimentation to engineer such elements for precise insertion of therapeutic genes into safe harbor sites of disease-relevant cells. Because Exsilio’s medicines are encoded in mRNA, they can be delivered using validated, non-viral delivery platforms that are safe, efficient, scalable, and cost-effective, and that allow redosing to effect with a curative intent.
keywords:N/A
N/A
Total Funding
38
Number of Employees
$5.3M
Revenue (est)
52%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.4M | 38 | 0% | N/A |
#2 | $6.4M | 38 | -14% | N/A |
#3 | $8.2M | 38 | 6% | N/A |
#4 | $6.4M | 38 | 0% | N/A |
#5 | $10M | 38 | -16% | N/A |